Related Experiment Video
Updated: Aug 18, 2026

Protocol for Relative Hydrodynamic Assessment of Tri-leaflet Polymer Valves
Published on: October 18, 2013
Medical treatment of valvular heart disease
1University of Cincinnati Medical Center, Ohio.
Abstract:
Despite recent advances in operative and percutaneous surgical techniques for valvular heart disease, medical management of complications of valvular disease, such as atrial fibrillation and infection, and prevention of thromboembolism remain important clinical problems. This review discusses recent data that address the role of vasodilator therapy in valvular regurgitation, the management of severe, asymptomatic aortic stenosis, and studies pertinent to the treatment of complications of valvular heart disease. Although vasodilators are promising agents, their efficacy in delaying the need for valve replacment remains unproven.
Related Concept Videos
Mitral Regurgitation III: Medical Management
Mitral Stenosis III: Medical Management
Mitral Stenosis IV: Nursing Management
Aortic Regurgitation III: Medical Management
Rheumatic Heart Disease III: Medical Management
Cardiomyopathy V: Interprofessional Care

